Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature Adva AvisarYaron RiverEran Ben-Arye Review 23 August 2012 Pages: 1 - 7
The Piper Fatigue Scale-12 (PFS-12): psychometric findings and item reduction in a cohort of breast cancer survivors Bryce B. ReeveAngela M. StoverBarbara F. Piper Review 30 August 2012 Pages: 9 - 20
Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation Nivedita BanerjeeStephen TalcottSusanne U. Mertens-Talcott Preclinical Study 02 September 2012 Pages: 21 - 34
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer Esther H. LipsRita A. MukhtarI-SPY TRIAL Investigators Preclinical study 08 September 2012 Pages: 35 - 43
Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells Joomin LeeAnuradha SehrawatShivendra V. Singh Preclinical Study 11 September 2012 Pages: 45 - 56
Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells Qingsong ZhuLihua JinYi Huang Preclinical Study 14 September 2012 Pages: 57 - 66
Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer Veronique M. NeumeisterCatherine A. SullivanLyndsay Harris Preclinical Study 14 September 2012 Pages: 67 - 75
Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast Shuai LiCuicui YangLi Fu Preclinical Study 14 September 2012 Pages: 77 - 87
Recombinant viral protein VP1 suppresses HER-2 expression and migration/metastasis of breast cancer Shao-Wen HungChing-Feng ChiuShu-Mei Liang Preclinical study 15 September 2012 Pages: 89 - 105
Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients Naofumi OdaKenzo ShimazuShinzaburo Noguchi Preclinical study 18 September 2012 Pages: 107 - 116
Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6 Anna PodnosDavid A. ClarkReginald M. Gorczynski Preclinical study 28 September 2012 Pages: 117 - 127
Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer Long ChenJane E. DahlstromDanny Rangasamy Preclinical Study Open access 29 September 2012 Pages: 129 - 142
A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer J. VardyG. PondI. F. Tannock Clinical trial 06 September 2012 Pages: 143 - 151
Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype Nils D. ArvoldKevin S. OhBrian M. Alexander Clinical Trial 12 September 2012 Pages: 153 - 160
GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients Mary Anne QuintayoAlison F. MunroJohn M. S. Bartlett Clinical trial 14 September 2012 Pages: 161 - 168
Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics Erica L. MayerSteven J. IsakoffHarold J. Burstein Clinical Trial 23 September 2012 Pages: 169 - 178
Impact of biomarkers on clinical trial risk in breast cancer Jayson L. ParkerNadia LushinaGilberto Lopes Clinical Trial 25 September 2012 Pages: 179 - 185
Effect of a mixed solution of sodium hyaluronate and carboxymethyl cellulose on upper limb dysfunction after total mastectomy: a double-blind, randomized clinical trial Eun Joo YangEunyoung KangSung-Won Kim Clinical Trial 29 September 2012 Pages: 187 - 194
Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study Alina VrielingKatharina BuckJenny Chang-Claude Epidemiology 11 September 2012 Pages: 195 - 207
Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population M. ChanS. M. JiA. S. G. Lee Epidemiology 11 September 2012 Pages: 209 - 220
Cost effectiveness of new breast cancer radiotherapy technologies in diverse populations Heather Taffet GoldMary Katherine Hayes Epidemiology 15 September 2012 Pages: 221 - 229
The association between polymorphisms in the leptin receptor gene and risk of breast cancer: a systematic review and pooled analysis Li-qiang WangWei ShenGuo-Qing Tao Epidemiology 15 September 2012 Pages: 231 - 239
Genetic polymorphisms in centrobin and Nek2 are associated with breast cancer susceptibility in a Chinese Han population Hui WangYun-Tao XieWei-Gang Fang Epidemiology 23 September 2012 Pages: 241 - 251
Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence Carolyn L. SmithIlenia MigliaccioSteffi Oesterreich Epidemiology 27 September 2012 Pages: 253 - 265
Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 50 Barbara A. CohnMary Beth TerryPiera M. Cirillo Epidemiology Open access 28 September 2012 Pages: 267 - 275
Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women Kimberly A. BertrandA. Heather EliassenRulla M. Tamimi Epidemiology 28 September 2012 Pages: 277 - 287
Management of small HER2 overexpressing tumours Arnoud TempletonAlberto OcañaEitan Amir Brief Report 06 September 2012 Pages: 289 - 293
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers Kristen N. StevensXianshu WangFergus J. Couch Brief Report 26 September 2012 Pages: 295 - 302
Comment on the review by Joshi and Buehring James F. HollandBeatriz G.-T. Pogo Letter to the Editor 06 May 2012 Pages: 303 - 307
Dietary calcium intake, vitamin D levels, and breast cancer risk: a dose–response analysis of observational studies Zhiqiang HongChangwei TianXingliang Zhang Letter To The Editor 25 July 2012 Pages: 309 - 312
Treatment response evaluation by MRI in breast cancer patients receiving neoadjuvant chemotherapy: there is more than just pathologic complete response prediction M. B. I. Lobbes Letter to the Editor 02 August 2012 Pages: 313 - 314
Non-random distribution of breast cancer susceptibility loci on human chromosomes Khyber SaifyMostafa Saadat Letter to the Editor 22 August 2012 Pages: 315 - 318
A modified technology could significantly improve the visualization rate of the internal mammary sentinel lymph nodes in breast cancer patients Peng-fei QiuJuan-juan LiuYong-sheng Wang Letter to the Editor 06 September 2012 Pages: 319 - 321
